| Assessment Status | Rapid Review Complete |
| HTA ID | 25007 |
| Drug | Progesterone |
| Brand | Lubion® |
| Indication | Progesterone (Lubion®) is indicated in adults for luteal support as part of an assisted reproductive technology (ART) treatment programme in infertile women who are unable to use or tolerate vaginal preparations. |
| Assessment Process | |
| Rapid review commissioned | 29/01/2025 |
| Rapid review completed | 07/03/2025 |
| Rapid review outcome | A full HTA is not recommended. The NCPE recommends that Lubion® not be considered for reimbursement at the submitted price*. |
*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods) Act 2013.
